These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9415948)

  • 1. Pergolide in the management of restless legs syndrome: an extended study.
    Silber MH; Shepard JW; Wisbey JA
    Sleep; 1997 Oct; 20(10):878-82. PubMed ID: 9415948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
    Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
    Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study.
    Trenkwalder C; Hundemer HP; Lledo A; Swieca J; Polo O; Wetter TC; Ferini-Strambi L; de Groen H; Quail D; Brandenburg U;
    Neurology; 2004 Apr; 62(8):1391-7. PubMed ID: 15111679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of restless leg syndrome with pergolide--an open clinical trial.
    Winkelmann J; Wetter TC; Stiasny K; Oertel WH; Trenkwalder C
    Mov Disord; 1998 May; 13(3):566-9. PubMed ID: 9613756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.
    Staedt J; Wassmuth F; Ziemann U; Hajak G; Rüther E; Stoppe G
    J Neural Transm (Vienna); 1997; 104(4-5):461-8. PubMed ID: 9295178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dosage of pergolide in the treatment of restless legs syndrome.
    Noël S; Korri H; Vanderheyden JE
    Acta Neurol Belg; 1998 Mar; 98(1):52-3. PubMed ID: 9606442
    [No Abstract]   [Full Text] [Related]  

  • 7. Pramipexole in the management of restless legs syndrome: an extended study.
    Silber MH; Girish M; Izurieta R
    Sleep; 2003 Nov; 26(7):819-21. PubMed ID: 14655914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome: treatment with dopaminergic agents.
    Comella CL
    Neurology; 2002 Feb; 58(4 Suppl 1):S87-92. PubMed ID: 11909990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of pergolide in the treatment of restless legs syndrome.
    Stiasny K; Wetter TC; Winkelmann J; Brandenburg U; Penzel T; Rubin M; Hundemer HP; Oertel WH; Trenkwalder C
    Neurology; 2001 May; 56(10):1399-402. PubMed ID: 11376198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
    Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
    Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of restless leg syndrome with pergolide.
    Gunning K; Gay C
    J Fam Pract; 1999 Apr; 48(4):250. PubMed ID: 10229243
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized controlled study of pergolide in patients with restless legs syndrome.
    Wetter TC; Stiasny K; Winkelmann J; Buhlinger A; Brandenburg U; Penzel T; Medori R; Rubin M; Oertel WH; Trenkwalder C
    Neurology; 1999 Mar; 52(5):944-50. PubMed ID: 10102410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.
    Earley CJ; Allen RP
    Sleep; 1996 Dec; 19(10):801-10. PubMed ID: 9085489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group.
    Walters AS; Mandelbaum DE; Lewin DS; Kugler S; England SJ; Miller M
    Pediatr Neurol; 2000 Mar; 22(3):182-6. PubMed ID: 10734247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleuropulmonary disease due to pergolide use for restless legs syndrome.
    Danoff SK; Grasso ME; Terry PB; Flynn JA
    Chest; 2001 Jul; 120(1):313-6. PubMed ID: 11451859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Punding in patients on dopamine agonists for restless leg syndrome.
    Evans AH; Stegeman JR
    Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline--an open clinical trial.
    Stiasny K; Röbbecke J; Schüler P; Oertel WH
    Sleep; 2000 May; 23(3):349-54. PubMed ID: 10811379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dopamine receptor agonists in the treatment of restless legs syndrome.
    Happe S; Trenkwalder C
    CNS Drugs; 2004; 18(1):27-36. PubMed ID: 14731057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M; Hundemer HP; Quail D; Riemann D; Voderholzer U; Trenkwalder C
    Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.
    Earley CJ; Yaffee JB; Allen RP
    Neurology; 1998 Dec; 51(6):1599-602. PubMed ID: 9855508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.